HIGHLIGHTS
- who: Robert Uzel and colleagues from the Department of Internal Medicine, Saint John of God Hospital, Teaching Hospital of the Paracelsus Medical Private University, Kajetanerplatz, Salzburg, Austria have published the paper: Clinical Impact of ACE-I/ARB for Conservatively Treated Patients with Moderate to Severe Mitral Regurgitation: A Single Center Observational Study, in the Journal: (JOURNAL) of 15/04/2023
- what: The aim of this study was to evaluate the impact of inhibitors and angiotensin receptor blockers (ACE-I/ARB) on elderly patients with moderate-to-severe MR and mildly reduced to preserved ejection fraction . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.